Adler, G., Mueller, B., & Articus, K. (2014). The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions. Int J Clin Pract.
Stile di citazione ChicagoAdler, G., B. Mueller, e K. Articus. "The Transdermal Formulation of Rivastigmine Improves Caregiver Burden and Treatment Adherence of Patients With Alzheimer's Disease Under Daily Practice Conditions." Int J Clin Pract 2014.
Citazione MLAAdler, G., B. Mueller, e K. Articus. "The Transdermal Formulation of Rivastigmine Improves Caregiver Burden and Treatment Adherence of Patients With Alzheimer's Disease Under Daily Practice Conditions." Int J Clin Pract 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.